Genix Pharmaceuticals Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA37232A1093
CAD
0.03
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Genix Pharmaceuticals Corp. stock-summary
stock-summary
Genix Pharmaceuticals Corp.
Pharmaceuticals & Biotechnology
Genix Pharmaceuticals Corporation, formerly Alta Natural Herbs & Supplements Ltd, is a dietary supplements and neutraceuticals company. It manufactures and converts dietary supplements and neutraceuticals (herbal, botanical and marine-based) for the natural healthcare products industry. It develops and manufactures a range of dietary supplements and neutraceuticals for the supplement industry. It is a contract manufacturer/converter of raw material powders, with all conversion, from powders to capsules to bottling and packaging. Its raw material powders are encapsulated in hard gelatin or vegetarian capsules. It engages in the contract manufacturing of dietary supplements for a range of customers ranging from naturopathic practitioners to chains. It operates a Cafe, which serves health meals, drinks, function foods and supplies nutrition supplements. It produces and distributes various dietary supplements into Hong Kong, South Korea, Germany and Italy.
Company Coordinates stock-summary
Company Details
Suite 300, 1055 West Hastings Street , VANCOUVER BC : V6E 1J8
stock-summary
Tel: 1 604 7109461
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jamie Lewin
Chief Financial Officer, Director
Dr. Conny Lin
Director
Dr. William Xiong
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2025)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 2 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.51

stock-summary
Return on Equity

39.34%

stock-summary
Price to Book

-1.25